Simple Blood Test Predicts Heart-Kidney Risk in Type 2 Diabetes!

canagliflozin,Imagine a world where a simple blood test could predict the future of your heart and kidney health if you have Type 2 diabetes. Well, new research published in the American Heart Association's journal Circulation brings us closer to that reality.

This study involved over 2,500 individuals with Type 2 diabetes and kidney disease. Researchers identified four special biomarkers in their blood that hold a powerful secret. 

These biomarkers turned out to be strong predictors of heart and kidney complications. But here's the exciting part – a potential solution emerged. 

People at the highest risk who took a medication called canagliflozin, which is known as a sodium glucose co-transporter 2 inhibitor, saw their biomarker levels drop. And as a result, their risk of heart failure and other heart problems decreased significantly. 

Those who took canagliflozin experienced a 3% to 10% decrease in biomarker levels after just one year, compared to those who took a placebo and saw an increase of 6% to 29%. 

This breakthrough fits like a missing puzzle piece. Doctors can now more accurately predict complications and tailor treatments for people with Type 2 diabetes and kidney disease.

But the journey doesn't stop here. More research is needed to fully understand how Type 2 diabetes and kidney disease interact. It's a step closer to personalized care, early interventions, and a healthier future.

Sources:-https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065251 

Disclaimer:-This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment.Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki. 

Find us at: 

https://www.instagram.com/medwiki_/?h... 

https://twitter.com/medwiki_inc 

https://www.facebook.com/medwiki.co.in/